glp 1 expected weight loss GLP-1 Medications: Everything You Need to Know Two Years After Stopping GLP-1s,
Description
The clinical evidence linking GLP-1 drugs to NAION is significant

Some patients carry genetic variants in the GLP1R gene (such as rs6923761) that naturally reduce receptor sensitivity, making them reach a plateau sooner than others

Join our community Thrive Daily Your daily guide to feeling your best with practical, science-backed tips Get the free GLP-1 Guide Crafted by experts to aid your weight loss journey

[DOI] [PubMed] [Google Scholar] Xiao Q, Jeng W, Wheeler MB

& Lynch, S

Tirzepatide is a synthetic peptide medication derived from the structure of human gastric inhibitory polypeptide (GIP), engineered to activate both GIP and glucagon-like peptide-1 (GLP-1) receptors
